CRISPR/Cas9 technology: A promising gene-editing tool for the treatment of cancers

Clustered regularly interspaced palindromic repeats (crispr) technology is an innovative gene-editing technique that has emerged as a result of the development of genetic engineering. this technology has expanded the scope of oncology-related medical research and clinical applications. crispr is used in molecular techniques to decode genes and pathways, alter the expression of specific genes for therapeutic purposes, and comprehend the pathophysiology of cancer. if pre-clinical research with this technology is successful, it could lead to clinical trials and eventually be used in clinical therapy. to establish the crispr complex as a promising tool in oncology for effective clinical cancer therapy, a variety of crispr variants and applications, as well as numerous experimental techniques, are being developed at present. this review examines several crispr technology variations, their application in oncology, as well as the system's advantages and disadvantages in comparison to earlier gene-editing technologies. it also discusses the recently discovered capabilities of the technology and its potential future applications in oncology.